Form 4 holding
Senior VP, Chief Pharma Dev.
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 5,789
- Estimated value
- $1,995,798
- Report date
- 05 Mar 2025
- Price
- $344.76
- Ownership
- Direct
Robert E. Waltermire - Senior VP, Chief Pharma Dev. at MADRIGAL PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Senior VP, Chief Pharma Dev.
- Issuer ticker
- MDGL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert E. Waltermire since 11 Aug 2025
Reported holdings for Robert E. Waltermire in MADRIGAL PHARMACEUTICALS, INC.
Form 4 holding
Senior VP, Chief Pharma Dev.
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 1,157
- Estimated value
- Report date
- 05 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert E. Waltermire in MADRIGAL PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.